Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis: A Randomized Clinical Trial.

Uloženo v:
Podrobná bibliografie
Název: Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis: A Randomized Clinical Trial.
Autoři: Li, Xiaojiao, Li, Bing, Yang, Deming, Wang, Meng, Li, Qianqian, Wang, Nan, Fang, Min, Liu, Jingrui, Zhang, Hong, Wu, Min, Li, Cuiyun, Zhu, Xiaoxue, Ding, Yanhua, Li, Shanshan
Zdroj: JAMA Dermatology; Mar2025, Vol. 161 Issue 3, p247-255, 9p
Databáze: Complementary Index
Popis
ISSN:21686068
DOI:10.1001/jamadermatol.2024.5059